n (%) | |
---|---|
Age at diagnosis | |
≤50 years | 133 (46) |
>50 years | 158 (54) |
Race | |
Caucasian | 239 (82) |
African-American | 52 (18) |
Stage and node status | |
Stage 1 | 82 (28) |
Stage 2 negative | 57 (20) |
Stage 2 positive | 87 (30) |
Stage 3 | 48 (16) |
Stage 4 | 17 (6) |
Estrogen receptor status | |
Positive | 176 (64) |
Negative | 101 (36) |
Progesterone receptor status | |
Positive | 128 (46) |
Negative | 148 (54) |
Treatment | |
Chemotherapy only | 95 (33) |
Radiation only | 25 (9) |
Chemotherapy/radiation | 54 (19) |
radiation/tamoxifen | 36 (12) |
Chemotherapy/tamoxifen | 44 (16) |
Chemotherapy/radiation/tamoxifen | 35 (12) |